Evidence map›Paper›PMID 41381792›Full record

ArticleScientific reports2025

The p.L218P variant in WDR83 disrupts neuronal development, leading to neurodevelopmental disorder.

Hidenori Tabata, Yuiko Hasegawa, Kumiko Yanagi, Ryota Sugawara, Hidenori Ito, Eriko Nishi, Tadashi Kaname, Nobuhiko Okamoto, Koh-Ichi Nagata

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hidenori TabataDepartment of Molecular Neurobiology, Aichi Developmental Disability Center, Institute for Developmental Research, Kasugai, 480-0392, Japan.
Yuiko HasegawaDepartment of Medical Genetics and Department of Molecular Medicine, Research Institute, Osaka Women's and Children's Hospital, Izumi, Osaka, Japan.
Kumiko YanagiDepartment of Genome Medicine, National Center for Child Health and Development, Tokyo, Japan.
Ryota SugawaraDepartment of Molecular Neurobiology, Aichi Developmental Disability Center, Institute for Developmental Research, Kasugai, 480-0392, Japan.
Hidenori ItoDepartment of Molecular Neurobiology, Aichi Developmental Disability Center, Institute for Developmental Research, Kasugai, 480-0392, Japan.
Eriko NishiDepartment of Medical Genetics and Department of Molecular Medicine, Research Institute, Osaka Women's and Children's Hospital, Izumi, Osaka, Japan.
Tadashi KanameDepartment of Genome Medicine, National Center for Child Health and Development, Tokyo, Japan.
Nobuhiko OkamotoDepartment of Medical Genetics and Department of Molecular Medicine, Research Institute, Osaka Women's and Children's Hospital, Izumi, Osaka, Japan. genetics@wch.opho.jp.
Koh-Ichi NagataDepartment of Molecular Neurobiology, Aichi Developmental Disability Center, Institute for Developmental Research, Kasugai, 480-0392, Japan. knagata@inst-hsc.jp.

Funding

Japan Agency for Medical Research and Development 24ek0109760h0001Japan Society for the Promotion of Science 23K24310, 22K19498, 24K02424, and 25K02630
6 · The paper itself

Abstract

WDR83 (WD Repeat Domain 83), also known as MORG1 (Mitogen-activated protein kinase Organizer 1), functions as a scaffold protein regulating diverse cellular processes, including cell signaling, proliferation, protein degradation, cell polarity, and autophagy. Through whole-exome sequencing, we identified a novel de novo WDR83 variant [NM_001099737; c.653 T > C,p.(L218P)] in a Japanese female patient presenting with global developmental delay, intellectual disability, and dysmorphic features. As the p.L218P variant was suspected to exert a dominant-negative effect, we investigated its impact on neuronal development. In vivo, acute expression via in utero electroporation promoted premature cell cycle exit of neural stem cells, impaired cortical neuron migration, and disrupted dendritic arborization, whereas axonal projections to the contralateral hemisphere remained unaffected. Additionally, cortical neurons expressing WDR83-L218P exhibited reduced spine head diameter. In vitro, WDR83-L218P expression inhibited axon elongation in primary cultured hippocampal neurons. Collectively, these findings suggest that WDR83 is a novel gene associated with neurodevelopmental disorders. Based on expression profiles and functional analyses, we conclude that WDR83 plays a crucial role in regulating neuronal morphology during brain development, and that the p.L218P variant disrupts this function, contributing to the patient's phenotype.

Indexed as

Adaptor Proteins, Signal TransducingNeurodevelopmental DisordersNeuronsAnimalsCell MovementExome SequencingFemaleHippocampusHumansMiceNeural Stem CellsNeurogenesisAdaptor Proteins, Signal TransducingCorticogenesisMORG1Neurodevelopmental disorderWDR83

Identifiers

PMID41381792
PMCPMC12816048

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.